These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 19158038)
1. Basal and triple-negative breast cancers: impact on clinical decision-making and novel therapeutic options. Voduc D; Nielsen TO Clin Breast Cancer; 2008 Dec; 8 Suppl 4():S171-8. PubMed ID: 19158038 [TBL] [Abstract][Full Text] [Related]
2. Triple-negative/basal-like breast cancer: clinical, pathologic and molecular features. Venkitaraman R Expert Rev Anticancer Ther; 2010 Feb; 10(2):199-207. PubMed ID: 20131996 [TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy of triple-negative breast cancer. Arslan C; Dizdar O; Altundag K Expert Opin Pharmacother; 2009 Sep; 10(13):2081-93. PubMed ID: 19640211 [TBL] [Abstract][Full Text] [Related]
4. Treatment of triple negative breast cancer (TNBC): current options and future perspectives. De Laurentiis M; Cianniello D; Caputo R; Stanzione B; Arpino G; Cinieri S; Lorusso V; De Placido S Cancer Treat Rev; 2010 Nov; 36 Suppl 3():S80-6. PubMed ID: 21129616 [TBL] [Abstract][Full Text] [Related]
5. Triple-negative breast cancer: molecular features, pathogenesis, treatment and current lines of research. Bosch A; Eroles P; Zaragoza R; ViƱa JR; Lluch A Cancer Treat Rev; 2010 May; 36(3):206-15. PubMed ID: 20060649 [TBL] [Abstract][Full Text] [Related]
6. What is triple-negative breast cancer? Irvin WJ; Carey LA Eur J Cancer; 2008 Dec; 44(18):2799-805. PubMed ID: 19008097 [TBL] [Abstract][Full Text] [Related]
7. Molecular stratification of triple-negative breast cancers. Perou CM Oncologist; 2011; 16 Suppl 1():61-70. PubMed ID: 21278442 [TBL] [Abstract][Full Text] [Related]
8. Directed therapy of subtypes of triple-negative breast cancer. Carey LA Oncologist; 2011; 16 Suppl 1():71-8. PubMed ID: 21278443 [TBL] [Abstract][Full Text] [Related]
9. What is the difference between triple-negative and basal breast cancers? Seal MD; Chia SK Cancer J; 2010; 16(1):12-6. PubMed ID: 20164685 [TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of the triple-negative breast cancer concept: genetic basis and clinical utility of the concept. Linn SC; Van 't Veer LJ Eur J Cancer; 2009 Sep; 45 Suppl 1():11-26. PubMed ID: 19775601 [TBL] [Abstract][Full Text] [Related]
11. Molecular stratification of triple-negative breast cancers. Perou CM Oncologist; 2010; 15 Suppl 5():39-48. PubMed ID: 21138954 [TBL] [Abstract][Full Text] [Related]
12. Possible treatment strategies for triple-negative breast cancer on the basis of molecular characteristics. Kurebayashi J Breast Cancer; 2009; 16(4):275-80. PubMed ID: 19408071 [TBL] [Abstract][Full Text] [Related]
13. Triple negative breast carcinoma and the basal phenotype: from expression profiling to clinical practice. Diaz LK; Cryns VL; Symmans WF; Sneige N Adv Anat Pathol; 2007 Nov; 14(6):419-30. PubMed ID: 18049131 [TBL] [Abstract][Full Text] [Related]
14. Current data of targeted therapies for the treatment of triple-negative advanced breast cancer: empiricism or evidence-based? Petrelli F; Cabiddu M; Ghilardi M; Barni S Expert Opin Investig Drugs; 2009 Oct; 18(10):1467-77. PubMed ID: 19737114 [TBL] [Abstract][Full Text] [Related]
16. Promising therapeutic options in triple-negative breast cancer. Bilici A; Arslan C; Altundag K J BUON; 2012; 17(2):209-22. PubMed ID: 22740196 [TBL] [Abstract][Full Text] [Related]
17. Triple-negative breast cancer: role of the androgen receptor. Gucalp A; Traina TA Cancer J; 2010; 16(1):62-5. PubMed ID: 20164692 [TBL] [Abstract][Full Text] [Related]
18. Beyond triple-negative breast cancer: the need to define new subtypes. Constantinidou A; Jones RL; Reis-Filho JS Expert Rev Anticancer Ther; 2010 Aug; 10(8):1197-213. PubMed ID: 20735307 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic strategies for triple-negative breast cancer. Tan AR; Swain SM Cancer J; 2008; 14(6):343-51. PubMed ID: 19060597 [TBL] [Abstract][Full Text] [Related]
20. Clinical significance of basal-like subtype in triple-negative breast cancer. Yamamoto Y; Ibusuki M; Nakano M; Kawasoe T; Hiki R; Iwase H Breast Cancer; 2009; 16(4):260-7. PubMed ID: 19701681 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]